Automated laser technology for safer laryngeal surgery
Image-guided automated ultrafast laser device for laryngeal surgery to expand treatment options and improve patient outcomes
This study is testing a new laser system for throat surgery that helps doctors be more precise and reduce risks, making recovery easier for patients.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Femtovox Incorporated NIH-funded |
| Lab location | 1 site (Ladera Ranch, United States) |
| Project ID | NIH-11005911 on NIH RePORTER |
What this research studies
This research focuses on developing an advanced laser system designed for laryngeal surgery, which aims to improve surgical precision and reduce complications. By utilizing real-time imaging technology, surgeons can accurately determine the depth of tissue excision, minimizing damage to surrounding areas. The ultrafast laser technology operates with extremely short pulse durations, which helps to eliminate collateral damage and enhance patient recovery times. This innovative approach seeks to address the limitations of traditional surgical methods, ultimately leading to better patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals scheduled for laryngeal surgery, particularly those with benign lesions or other conditions affecting the larynx.
Not a fit: Patients who do not require laryngeal surgery or have conditions that do not involve the larynx may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective laryngeal surgeries, reducing recovery times and complications for patients.
How similar studies have performed: Previous research in automated laser technologies for surgical applications has shown promising results, indicating potential for success in this novel approach.
Where this research is happening
Ladera Ranch, United States
- Femtovox Incorporated — Ladera Ranch, United States (Active)
Researchers
- Principal investigator: Sharma, Manu — Femtovox Incorporated
- Study coordinator: Sharma, Manu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.